Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Anticancer Research is Scopus-indexed (Q3, CiteScore 3.4), WoS SCIE. Published by International Institute of Anticancer Research.
Checked against the index lists dated .
ISSN 0250-7005Verify ISSN ↗1791-7530Verify ISSN ↗
Publisher: International Institute of Anticancer Research
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 250 / 428 | 41st | Q3 |
| Cancer Research | 172 / 233 | 26th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1981–present, best quartile Q3, CiteScore 3.4.
Anticancer Research is Q3 in Oncology (rank 250 of 428) and Q3 in Cancer Research (rank 172 of 233), by CiteScore 2025.
Anticancer Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.4, which places it in quartile Q3 at the 41st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.580, quartile Q2, with an H-index of 145.
Anticancer Research is published by International Institute of Anticancer Research. Its print ISSN is 0250-7005 and its online ISSN is 1791-7530.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Anticancer Research has an h-index of 79 and a 2-year mean of 1.55 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q3. On 2-year citations it ranks #237 of 424 Scopus journals in Oncology.
Anticancer Research published 539 papers in 2025; its busiest recent year was 2018 with 963. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from Japan (60.4%), South Korea (9.9%) and United States (7.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.